AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE
AND
FEDERAL FOCUS, INC.

BRIEFING ON OMB REVISIONS TO CIRCULAR A-110 REGARDING PUBLIC ACCESS TO DATA

Introduction
Program (with links to proceedings of briefing presentations and Q/A)
AAAS Letter to OMB, September 10, 1999
AAAS Letter to OMB, April 2, 1999
AAAS Letter to Congressional Members
AAAS Resolution

 


At the end of last year's session, Congress passed an Omnibus Appropriations Bill which includes a provision requiring the Office of Management and Budget to amend Circular A-110 to "ensure that all data produced under an award will be made available to the public through the procedures established under the Freedom of Information Act." Although well-meaning in its intent to promot public access to scientific data, it has raised concerns among researchers and their institutions about how it would be implemented. Questions arise regarding the costs of implementation, the confidentiality of human subjects research data, and its impact on intellectual property rights and university-industry relationships. To address these and other issues as well as the proposed rule issued by OMB, the American Association for the Advancement of Science and Federal Focus, Inc. will convene a briefing on February 26, 1999. Representatives from OMB, the House Committee on Science Staff, National Institutes of Health, industry, and the research community will be present.

 

PROGRAM


February 26, 1999
AAAS Auditorium
1200 New York Avenue, NW
Washington, DC 20005

9.00 am Continental Breakfast
9.30 am Welcome
  Mark S. Frankel, Program in Scientific Freedom, Responsibility and Law, AAAS
9.35 am Panel on Proposed Revision of OMB Circular A-110
  Milton Goldberg, Council on Governmental Relations
9.40 am Origins of Congressional Action Regarding Public Access to Data
  Ms. Kathy Casey, Legislative Director, Office of Senator Richard Shelby
10.05 am Implications of the Legislation: A View From the Hill
  Dr. Jean Fruci, Professional Staff Member of the Technology Subcommittee, House Science Committee
10.30 am The Proposed OMB Revision and the Federal Agencies
  Dr. Wendy Baldwin, Deputy Director for Extramural Research, NIH
10.55 am The University Community and the A-110 Proposed Revision
  Dr. Mary Ellen Sheridan, Assistant Vice President for Research, University of Chicago
11.20 am An Industry Perspective on the Proposed Revision
  Dr. Roger McClellan, President, Chemical Industry Institute of Toxicology
11.45 am An Inside View of the Proposed Revision from OMB
  Mr. Marc Garufi, Program Examiner, Health Division, OMB
12.15 pm Wrap Up*
12.30 pm Briefing Adjourns
   
  *The transcript for the Wrap Up section includes general questions from the audience and panelists' answers.